Helen Bright

Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail

Jinhui Dong, Seth J. Zost, Allison J. Greaney et al. · Nature Microbiology · 2021 · 330 citations · Full text

Pharmacy, Immunology, Molecular Biology +17

The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans

Yueh–Ming Loo, Patrick M. McTamney, Rosalinda H. Arends et al. · Science Translational Medicine · 2022 · 215 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin

Maria-Ana Ghetie, Helen Bright, Ellen S. Vitetta · Blood · 2001 · 190 citations · Full text

Medicine, Oncology, Pharmacology +17

Development of a GB Virus B Marmoset Model and Its Validation with a Novel Series of Hepatitis C Virus NS3 Protease Inhibitors

Helen Bright, Anthony R. Carroll, Paul Watts et al. · Journal of Virology · 2004 · 87 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Induction, Duration, and Resolution of Airway Goblet Cell Hyperplasia in a Murine Model of Atopic Asthma: Effect of Concurrent Infection with Respiratory Syncytial Virus and Response to Dexamethasone

David I. Blyth, Michael S. Pedrick, Tony J. Savage et al. · American Journal of Respiratory Cell and Molecular Biology · 1998 · 84 citations

Life Sciences, Immunology, Pathobiology +14